文献速递临床试验与 GCP

腹腔镜腹股沟韧带悬吊术与腹腔镜骶骨固定术治疗盆腔器官脱垂的随机对照试验研究方案

Laparoscopic inguinal ligament suspension versus laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-03-05

盆腔器官脱垂(POP)终生手术风险为11%,腹腔镜骶骨固定术(LSC)被视为金标准但技术难度大。本研究为多中心随机对照非劣效性试验,比较新术式腹腔镜腹股沟韧带悬吊术(LILS)与LSC在II期及以上子宫脱垂女性中的疗效与安全性,主要结局包括围手术期参数和POP-Q解剖结果,计划每组107例。

要点

  • POP终生手术风险为11%,LSC是期望重建手术女性的金标准。
  • LILS是新术式,需随机对照试验比较其与LSC的疗效与安全性。
  • 主要结局为围手术期参数及术后5年内POP-Q解剖结果。

核心结论

  • 本试验将提供证据判断LILS在症状性II期及以上子宫脱垂女性中的疗效与安全性是否非劣于LSC。

研究设计与样本

  • 多中心随机对照非劣效性试验,比较LILS与LSC在II期及以上子宫脱垂女性中的效果。
  • 基于客观成功率90%、非劣效界值15%、脱落率20%,每组需107例患者,以95%置信区间验证假设。
  • 数据分析遵循意向性治疗原则,使用经验证的问卷。

主要发现

  • 原文为研究方案,未报告试验结果。

关键数值与推荐

  • 主要结局包括手术时间、出血量、术中并发症、住院时间及术后6周、6个月、12个月及每年至5年的POP-Q分度解剖结果。
  • 次要结局包括泌尿生殖症状主观改善、生活质量、术后并发症、术后恢复、性功能及成本效果。

临床怎么用

  • 若LILS非劣于LSC,可为POP患者提供技术难度更低的手术选择。

局限性

  • 原文为研究方案,尚无结果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pelvic organ prolapse (POP) is a common health problem. The lifetime risk of undergoing surgery for prolapse is 11%. POP significantly affects the effects on quality of life and activities of daily living. Laparoscopic sacrocolpopexy (LSC) has been viewed as the gold standard treatment for women with POP who desire reconstructive surgery. However, LSC is associated with technical difficulties, resulting in a long learning curve and operative time. Recently, our team introduced a new laparoscopic technique of inguinal ligament suspension (LILS) and had confirmed its safety and efficacy in treating vaginal vault prolapse. As a new surgical technique for POP, a prospective randomized controlled trial comparing the LILS with the standard technique of LSC is necessary. Therefore, we will conduct a trial. METHODS: The trial is a randomized controlled trial. It compares LILS with LSC in women with stage 2 or higher uterine prolapse. The primary outcomes of this study are perioperative parameters, including surgical time, blood loss, intraoperative complications, and hospital stay as well as surgical anatomical results using the pelvic organ prolapse questionnaire (POP-Q) classification at 6 weeks, 6 months, 12 months, and annually till 5 years after surgery. Secondary outcomes are subjective improvement in urogenital symptoms and quality of life, postoperative complications, postoperative recovery, sexual functioning, and cost-effectiveness at each follow-up point. Validated questionnaires will be used and the data will be analyzed according to the intention-to-treat principle. Based on an objective success rate of 90%, a noninferiority margin of 15%, and a dropout of 20%, 107 patients are needed in each arm to prove the hypothesis with a 95% confidence interval. DISCUSSION: The trial is a randomized controlled, multicenter, noninferiority trial that will provide evidence whether the efficacy and safety of LILS is noninferior to LSC in women with symptomatic stage 2 or higher uterine prolapse. TRIAL REGISTRATION: China Trial Register (CTR): ChiCTR-INR-15007408 . Registered on 9 November 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li C, Dai Z, Shu H, et al. Laparoscopic inguinal ligament suspension versus laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29506566. doi:10.1186/s13063-018-2494-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。